Paper2860883
Antihypertensive therapy and lipids. Evidence, mechanisms, and implications.
Weinberger MH. Arch Intern Med, 1985. Cited by 201 papers, by iCite.
Cite this record
ConductScience Library. Antihypertensive therapy and lipids. Evidence, mechanisms, and implications. Papers, record 2860883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2860883
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antihypertensive Agents | Major topic |
| Coronary Disease | Major topic |
| Dietary Fats | Major topic |
| Hypertension | Major topic |
| Lipid Metabolism | Major topic |
| Adrenergic beta-Antagonists | |
| Cholesterol | |
| Diuretics | |
| Humans | |
| Lipoproteins | |
| Longitudinal Studies | |
| Male | |
| Risk | |
| Sympatholytics | |
| Triglycerides | |
| Vasodilator Agents |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 201 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39861195 | Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy-Challenges and Prospectives. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/39861195 | PubMed |
| 36945026 | The impact of rate and rhythm control strategies on quality of life for patients with atrial fibrillation: a protocol for a systematic review. | Syst Rev | 2023 | https://conductscience.org/library/papers/36945026 | PubMed |
| 8527351 | Comparison of the efficacy and safety of once-daily versus twice-daily formulations of diltiazem in the treatment of systemic hypertension. The Canadian Multicenter Diltiazem-CD Hypertension Trial Group. | Cardiovasc Drugs Ther | 1995 | https://conductscience.org/library/papers/8527351 | PubMed |
| 8133348 | Primary care of the renal transplant patient. | J Gen Intern Med | 1994 | https://conductscience.org/library/papers/8133348 | PubMed |
| 7875191 | Lack of interaction between ramipril and simvastatin. | Eur J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/7875191 | PubMed |
| 7556989 | A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM. | Diabetologia | 1995 | https://conductscience.org/library/papers/7556989 | PubMed |
| 3765601 | Antihypertensive therapy, serum lipids, coronary heart disease and hypertension--balancing the risks and benefits of treatment. | West J Med | 1986 | https://conductscience.org/library/papers/3765601 | PubMed |
| 3595696 | Serum lipids and lipoproteins in ischaemic heart disease following withdrawal of long-term metoprolol treatment. | Eur J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3595696 | PubMed |
| 3545419 | Billing numbers fight to continue despite court setback. | CMAJ | 1987 | https://conductscience.org/library/papers/3545419 | PubMed |
| 3319640 | Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension. | Eur J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3319640 | PubMed |
| 3190999 | Quinapril and blood lipids. | Br J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3190999 | PubMed |
| 3154682 | Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients. | Cardiovasc Drugs Ther | 1988 | https://conductscience.org/library/papers/3154682 | PubMed |
| 3154313 | Angiotensin converting enzyme inhibitors in the treatment of hypertension: efficacy, metabolic effects and side effects. | Cardiovasc Drugs Ther | 1987 | https://conductscience.org/library/papers/3154313 | PubMed |
| 3077110 | Value of non-drug treatment and drug treatment in hypertension. | Drugs | 1988 | https://conductscience.org/library/papers/3077110 | PubMed |
| 2939868 | A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/2939868 | PubMed |
| 2846658 | Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. | J Clin Invest | 1988 | https://conductscience.org/library/papers/2846658 | PubMed |
| 2655692 | Low and conventional dose cyclopenthiazide on glucose and lipid metabolism in mild hypertension. | Br J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2655692 | PubMed |
| 2565758 | Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension. | CMAJ | 1989 | https://conductscience.org/library/papers/2565758 | PubMed |
| 2518682 | Cost of antihypertensive treatment: a point of view from India. | Cardiovasc Drugs Ther | 1989 | https://conductscience.org/library/papers/2518682 | PubMed |
| 2488113 | Effects of pindolol and propranolol on blood lipids in hypertensive patients. | Cardiovasc Drugs Ther | 1989 | https://conductscience.org/library/papers/2488113 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2860883
GET https://conductscience.org/api/papers/v1/2860883/cited_by?page=2